Acquisition History NGD’s history of asset sales and acquisitions (sold assets to Vimian in 2022, acquired by Movora in 2023) suggests a company with strategic shifts and potential integration opportunities for veterinary devices and related services.

Vet market focus As a veterinary medical device manufacturer with a small team, NGD represents a niche player that could benefit from targeted partnerships or OEM agreements with larger veterinary distributors and clinics to expand reach.

Financial Signals Revenue is in the sub-million range, indicating a lean operation with potential for revenue growth through channel expansion, product line diversification, or add-on services for existing customers.

Tech Stack Utilization Digital infrastructure includes standard web tools and security measures (Cloudflare, reCAPTCHA, GTM), suggesting readiness for enhanced online sales, demand generation, and customer self-service features to improve conversion.

Growth Opportunities Recent ownership changes and a small employee base signal opportunities for scalable partnerships, distribution deals, and co-development of new veterinary device solutions aligned with market trends.